SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-062794
Filing Date
2011-11-10
Accepted
2011-11-10 10:25:06
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v239155_10q.htm 10-Q 625808
2 EXHIBIT 31.1 v239155_ex31-1.htm EX-31.1 10515
3 EXHIBIT 31.2 v239155_ex31-2.htm EX-31.2 10642
4 EXHIBIT 32.1 v239155_ex32-1.htm EX-32.1 6796
5 EXHIBIT 32.2 v239155_ex32-2.htm EX-32.2 6832
  Complete submission text file 0001144204-11-062794.txt   1767312

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20110930_pre.xml EX-101.PRE 94961
7 XBRL INSTANCE DOCUMENT rprx-20110930.xml EX-101.INS 109331
8 XBRL TAXONOMY EXTENSION SCHEMA rprx-20110930.xsd EX-101.SCH 13462
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20110930_cal.xml EX-101.CAL 37333
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20110930_def.xml EX-101.DEF 87565
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20110930_lab.xml EX-101.LAB 98675
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 111193676
SIC: 2836 Biological Products, (No Diagnostic Substances)